Back to search

Article

Identification of neoantigens in esophageal adenocarcinoma

2022-05-04

Abstract excerpt

Esophageal adenocarcinoma (EAC) has a relatively poor long-term survival and limited treatment options. Promising targets for immunotherapy are short peptide neoantigens containing tumor mutations, presented to cytotoxic T-cells by human leukocyte antigen molecules (HLA). Despite an association between putative neoantigen abundance and therapeutic response across cancers, immunogenic neoantigens are challenging to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e4c1e058-3fc7-5f7c-bb75-de1a354ec82e
DOI
10.1101/2022.05.04.490567
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identification of neoantigens in esophageal adenocarcinomaDOI 10.1101/2022.05.04.490567
Select a neighboring publication to make it the new centre.